Featured
-
-
Article
| Open Access
Targeting the NTSR2/TrkB oncogenic pathway in chronic lymphocytic leukemia
- Léa Ikhlef
- , May Yassine
- & Paul-François Gallet
-
Article
| Open Access
Venetoclax efficacy on acute myeloid leukemia is enhanced by the combination with butyrate
- Renshi Kawakatsu
- , Kenjiro Tadagaki
- & Tatsushi Yoshida
-
Article
| Open Access
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin
- Mikael Lisak
- , Malin Nicklasson
- & Markus Hansson
-
Article
| Open Access
Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells
- Kristen S. Hill
- , Erin E. Schuler
- & Jill M. Kolesar
-
Article
| Open Access
Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy
- Lukasz Bolkun
- , Tomasz Pienkowski
- & Michal Ciborowski
-
Article
| Open Access
Pan-cancer analysis revealing that PTPN2 is an indicator of risk stratification for acute myeloid leukemia
- Xuanyu Wang
- , Sanyun Wu
- & Li He
-
Article
| Open Access
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia
- Candida Vitale
- , Valentina Griggio
- & Marta Coscia
-
Article
| Open Access
A pilot study of implication of machine learning for relapse prediction after allogeneic stem cell transplantation in adults with Ph-positive acute lymphoblastic leukemia
- Kseniia S. Afanaseva
- , Evgeny A. Bakin
- & Sergey N. Bondarenko
-
Article
| Open Access
Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment
- Thomas Burmeister
- , Daniela Gröger
- & Stefan Schwartz
-
Article
| Open Access
The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism
- Benjamin C. S. Leow
- , Chung H. Kok
- & Laura N. Eadie
-
Article
| Open Access
Concentration of low-density lipoproteins (LDL) is significantly reduced after nilotinib discontinuation
- Ricardo Roa-Chamorro
- , José Manuel Puerta-Puerta
- & Juan Diego Mediavilla-García
-
Article
| Open Access
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience
- Paul Jäger
- , Christina Rautenberg
- & Guido Kobbe
-
Article
| Open Access
Efficacy and safety of add-on anti-CD20 monoclonal antibody to Bruton tyrosine kinase inhibitor treatment for chronic lymphocytic leukemia: a meta-analysis
- Thi Thuy Nguyen
- , Nguyen Thanh Nhu
- & Chiou-Feng Lin
-
Article
| Open Access
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
- Haruka Hiroki
- , Yuko Ishii
- & Masatoshi Takagi
-
Article
| Open Access
The structure of the hematopoietic system can explain chronic myeloid leukemia progression
- Mario Pérez-Jiménez
- , Imre Derényi
- & Gergely J. Szöllősi
-
Article
| Open Access
Detection of acute promyelocytic leukemia in peripheral blood and bone marrow with annotation-free deep learning
- Petru Manescu
- , Priya Narayanan
- & Delmiro Fernandez-Reyes
-
Article
| Open Access
FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling
- Sven Liebig
- , Martin Neumann
- & Claudia D. Baldus
-
Article
| Open Access
Outdoor artificial light at night, air pollution, and risk of childhood acute lymphoblastic leukemia in the California Linkage Study of Early-Onset Cancers
- Charlie Zhong
- , Rong Wang
- & Xiaomei Ma
-
Article
| Open Access
Mechanism of KIT gene regulation by GATA1 lacking the N-terminal domain in Down syndrome–related myeloid disorders
- Rika Kanezaki
- , Tsutomu Toki
- & Etsuro Ito
-
Article
| Open Access
EEG-based grading of immune effector cell-associated neurotoxicity syndrome
- Daniel K. Jones
- , Christine A. Eckhardt
- & M. Brandon Westover
-
Article
| Open Access
Prognostic prediction of novel risk scores (AML-DRG and AML-HCT-CR) in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation
- Weijie Cao
- , Xiaoning Li
- & Jifeng Yu
-
Article
| Open Access
Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome
- Panagiotis T. Diamantopoulos
- , Emmanouil Charakopoulos
- & Athanasios Galanopoulos
-
Article
| Open Access
Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia
- Maddalena Marconato
- , Joseph Kauer
- & Jonas S. Heitmann
-
Article
| Open Access
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12
- Rae Hunter
- , Kathleen J. Imbach
- & Christopher C. Porter
-
Article
| Open Access
Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis
- Barbara Tomic
- , Tomislav Smoljo
- & Dora Visnjic
-
Article
| Open Access
Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia
- Suvi P. M. Douglas
- , Atte K. Lahtinen
- & Outi Kilpivaara
-
Article
| Open Access
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML
- Emmanuel Gyan
- , Arnaud Pigneux
- & Olivier Hérault
-
Article
| Open Access
High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia
- Hajime Senjo
- , Masahiro Onozawa
- & Takanori Teshima
-
Article
| Open Access
scTEM-seq: Single-cell analysis of transposable element methylation to link global epigenetic heterogeneity with transcriptional programs
- Kooper V. Hunt
- , Sean M. Burnard
- & Heather J. Lee
-
Article
| Open Access
Rotating between ponatinib and imatinib temporarily increases the efficacy of imatinib as shown in a chronic myeloid leukaemia model
- H. Jonathan G. Lindström
- & Ran Friedman
-
Article
| Open Access
RUNX3 overexpression inhibits normal human erythroid development
- Ana Catarina Menezes
- , Christabel Dixon
- & Alex Tonks
-
Article
| Open Access
The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients
- Minghao Li
- , Sheng-Li Xue
- & Lei Yu
-
Article
| Open Access
Integrated RNAi screening identifies the NEDDylation pathway as a synergistic partner of azacytidine in acute myeloid leukemia
- Justine Klosner
- , Konstantin Agelopoulos
- & Carsten Müller-Tidow
-
Article
| Open AccessIncidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis
- Sang-Min Oh
- , Ja Min Byun
- & Myoung-don Oh
-
Article
| Open Access
Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis
- Meike Farber
- , Yiyang Chen
- & Maher Hanoun
-
Article
| Open Access
Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18
- Michael Maher
- , Jeannine Diesch
- & Marcus Buschbeck
-
Article
| Open Access
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
- Tamara Castaño-Bonilla
- , Juan M. Alonso-Dominguez
- & Pau Montesinos
-
Article
| Open Access
Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia
- Jeremy M. Schraw
- , J. P. Woodhouse
- & Austin L. Brown
-
Article
| Open Access
KCTD15 deregulation is associated with alterations of the NF-κB signaling in both pathological and physiological model systems
- Giovanni Smaldone
- , Luigi Coppola
- & Peppino Mirabelli
-
Article
| Open Access
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia
- Crescenzio Francesco Minervini
- , Cosimo Cumbo
- & Francesco Albano
-
Article
| Open Access
Non-toxic polymer nanovectors for improved delivery of dexamethasone
- Benjamin C. Ede
- , Paraskevi Diamanti
- & Allison Blair
-
Article
| Open Access
Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia
- Shumaila Sayyab
- , Anders Lundmark
- & Ann-Christine Syvänen
-
Article
| Open Access
Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia
- Youjin Wang
- , Weiyin Zhou
- & Shahinaz M. Gadalla
-
Article
| Open Access
Focused CRISPR-Cas9 genetic screening reveals USO1 as a vulnerability in B-cell acute lymphoblastic leukemia
- Amit Kumar Jaiswal
- , Hellen Truong
- & Dinesh S. Rao
-
Article
| Open Access
Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
- Ana Colado
- , Esteban Enrique Elías
- & Mercedes Borge
-
Article
| Open Access
Transcriptional drug repositioning and cheminformatics approach for differentiation therapy of leukaemia cells
- Yasaman KalantarMotamedi
- , Fatemeh Ejeian
- & Andreas Bender
-
Article
| Open Access
Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein
- Tyler W. Jenkins
- , Sondra L. Downey-Kopyscinski
- & Alexei F. Kisselev
-
Article
| Open Access
IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen
- Marta Libura
- , Emilia Bialopiotrowicz
- & Olga Haus
-
Article
| Open Access
Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia
- Yao Xue
- , Jing Chen
- & Yongjun Fang
Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia